Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Raises Questions Disappointing Mounjaro and Zepbound sales may be due more to quarterly variability than slowing demand, but LLYs plan to boost marketing efforts raises questions, Steve Scala, managing director, Health Care-Pharmaceuticals (Major) with TD Cowen, wrote Wednesday in a research note
(9) A study that followed 655 advanced melanoma patients on Keytruda delivered more promising news
Patients with risk factors such as obesity, extended diabetes duration, or specific medication use might need extra monitoring
2011;300:H2196-2205
Importantly, this was not driven by aggressive rebate engineering
Because these events are differentially regulated by the three limbs of the UPR, our data suggest that etomoxir diminishes signaling from all three UPR pathways
US$ 22.42
US$ 20.10
US$ 21.29
